In addition, a recent study by Moscoso et al. (2025) in JAMA highlights the prognostic value of tau PET imaging, demonstrating that individuals who are both Aβ- and tau-positive have a significantly elevated risk of clinical conversion from preclinical to MCI or dementia [40]. This evidence concerns the gene MAPT and dementia.